Lord’s Mark Industries aims to go public in 2024 

Plans to raise up to Rs 500 crores and invest the proceeds in its subsidiaries to develop medtech products 

Lord’s Mark Industries, a diversified business group, has announced that it is aiming to hit the capital markets and go for public listing in the first half of 2024 to raise up to Rs. 500 crores. IDBI Capital and Mirae Asset are the merchant bankers for the listing.

Lord’s Mark Industries to invest the proceeds in its subsidiaries to develop medtech products, produce innovative diagnostic solutions, expand its pathology lab pan India and export its medical diagnostic products and machines.

Sachidanand Upadhyay, MD, Lord’s Mark Industries said, “Our major business unit – Diagnostic-Medtech and innovative Solar-LED division has been breaking new ground with innovation and solution-oriented approach. Our subsidiaries, Lord’s Automative, Lord’s Mark Biotech, Lord’s Mark Microbiotech and Lord’s Mark Insurance Broking Services have plans to further deepen our market penetration and the listing will fuel our further growth.’’

Lord’s Mark Industries reported revenue from operations at Rs 301 crores in FY23, registering a 41.31 per cent growth from the revenue reported in FY22 which stood at Rs 213 crores.


Support us in our endeavor to bring you Advertisement free content.
Choose your options to donate or subscribe.


Related Articles

Back to top button